Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study

PURPOSE: In cases of non-small cell lung cancer (NSCLC), surgery remains the best option for cure, but surgery is of benefit only when the disease is localized. Although adjuvant chemotherapy reportedly has a significant beneficial effect on survival, the benefit of a carboplatin (CBDCA) regimen is...

Descripción completa

Detalles Bibliográficos
Autores principales: Takashima, Shinogu, Imai, Kazuhiro, Atari, Maiko, Matsuo, Tsubasa, Nakayama, Katsutoshi, Sato, Yusuke, Motoyama, Satoru, Shibata, Hiroyuki, Nomura, Kyoko, Minamiya, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545843/
https://www.ncbi.nlm.nih.gov/pubmed/33032626
http://dx.doi.org/10.1186/s12957-020-02041-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545843/
https://www.ncbi.nlm.nih.gov/pubmed/33032626
http://dx.doi.org/10.1186/s12957-020-02041-0

Ejemplares similares